Join the Liver and Pancreatic Disease group to help and get support from people like you.
Liver and Pancreatic Disease News (Page 3)
'Broken' Sleep Could Be Hallmark of Obesity-Linked Liver Disease
THURSDAY, Dec. 5, 2024 – Fatty liver disease may contribute to fragmented sleep patterns, robbing already sick people of good rest, a new study finds. These folks woke up more often in the night,...
PIVKA-II-Based Model IDs Liver Cancer Risk in Hep C-Related Cirrhosis
THURSDAY, Dec. 5, 2024 – Among patients with hepatitis C virus (HCV)-related cirrhosis with sustained virological response (SVR) to direct-acting antivirals (DAAs), a serum protein induced by...
AI Algorithm Can ID Metabolic Dysfunction-Associated Steatotic Liver Disease
WEDNESDAY, Nov. 27, 2024 – An algorithm can identify individuals with metabolic dysfunction-associated steatotic liver disease (MASLD) with about 88 percent accuracy using electronic medical record...
Alcohol-Induced Liver Disease Hospitalizations, Transplants on the Rise
THURSDAY, Nov. 21, 2024 – From 2005 to 2021, alcohol-induced liver disease (AILD)-related hospitalizations and liver transplants (LTs) increased among women and men and in younger and older adults,...
AI Helps Spot Liver Disease Early
MONDAY, Nov. 18, 2024 – AI can help doctors diagnose early cases of fatty liver disease, a new study says. An AI program trained to spot a leading type of the disease, called metabolic-associated...
Fatty Liver Disease Now Affects 4 in 10 U.S. Adults
WEDNESDAY, Nov. 13, 2024 – Obesity, alcohol use and other factors are driving up rates of fatty liver disease among American adults, new research warns. By 2018, federal data showed that 42% of...
Scientists Successfully Reverse Liver Fibrosis in Mice
FRIDAY, Nov. 1, 2024 – Cirrhosis, hepatitis infection and other causes can trigger liver fibrosis – a potentially lethal stiffening of tissue that, once begun, is irreversible. For many patients, a...
Small but Important Differences Seen Between Rosuvastatin, Atorvastatin
WEDNESDAY, Oct. 30, 2024 – There are small but important differences in risk for some clinical outcomes associated with rosuvastatin and atorvastatin, according to a study published online Oct. 29...
Referral to Hepatology Low With Excessive Alcohol Use, High FIB-4
MONDAY, Oct. 7, 2024 – Only 37 percent of patients with excessive alcohol use (EAU) and a high fibrosis-4 index (FIB-4) are referred to hepatology, according to a study published online Sept. 21 in...
Ozempic Could Curb Progression of Diabetes-Linked Liver Disease
MONDAY, Sept. 16, 2024 – Fatty liver disease linked to diabetes and obesity can easily progress to liver cirrhosis, but new research suggests that GLP-1 medicines like Ozempic can help stop that. In...
People With Chronic Liver Disease Face More Barriers to Health Care
THURSDAY, Aug. 29, 2024 – People with chronic liver disease (CLD) have a higher likelihood of barriers to health care, according to a study recently published in Gastro Hep Advances. Carrie R. Wong, ...
Outcomes Similar for Neoadjuvant ICI-Based Therapy, Upfront Surgery for Liver Cancer
THURSDAY, Aug. 22, 2024 – Patients treated with neoadjuvant immune checkpoint inhibitor (ICI)-based therapy for hepatocellular carcinoma (HCC) have higher-risk disease features but achieve outcomes...
New Definition of Steatotic Liver Disease Improves Prediction of Kidney Disease
TUESDAY, Aug. 20, 2024 – Using a new classification of steatotic liver disease (SLD) based on the presence of metabolic dysfunction and alcohol consumption, metabolic dysfunction-associated...